Featured Post from Cedarville University

Covering Remdesivir – Contact an expert from Cedarville first

May 4, 2020

2 min

Zach Jenkins


There has been a lot of talk about treatment, vaccinations and drugs that are being used during the CVOID-19 pandemic.


The latest is Remdesivir – and it is getting a lot of attention.


The US's Food and Drug Administration (FDA) has authorised emergency use of the Ebola drug remdesivir for treating the coronavirus.


The authorisation means the anti-viral drug can now be used on people who are hospitalised with severe Covid-19.


A recent clinical trial showed the drug helped shorten the recovery time for people who were seriously ill.


However, it did not significantly improve survival rates.


Experts have warned the drug - which was originally developed to treat Ebola, and is produced by Gilead pharmaceutical company in California - should not be seen as a "magic bullet" for coronavirus.




What do we know about remdesivir?


The drug did not cure Ebola, and Gilead says on its website: "Remdesivir is an experimental medicine that does not have established safety or efficacy for the treatment of any condition." Gilead also warns of possible serious side-effects.

However, President Trump has been a vocal supporter of remdesivir as a potential treatment for the coronavirus.


In its clinical trial, whose full results are yet to be released, the US National Institute of Allergy and Infectious Diseases (NIAID) found that remdesivir cut the duration of symptoms from 15 days down to 11.


The trials involved 1,063 people at hospitals around the world - including the US, France, Italy, the UK, China and South Korea. Some patients were given the drug and others were given a placebo (dummy) treatment.


Dr Anthony Fauci who runs NIAID, said that remdesivir had "a clear-cut, significant, positive effect in diminishing the time to recovery".


However, although remdesivir may aid recovery - and possibly stop people having to be treated in intensive care - the trials did not give any clear indication whether it can prevent deaths from coronavirus.  May 02 - BBC



There are still a lot of questions to be asked:


  • When could it be ready for mass distribution?
  • How is it administered?
  • Who can get it?
  • And how much will it cost?


If you are a journalist covering this emerging issue – then let our experts help.


Dr. Zach Jenkins is an infectious disease expert at Cedarville University. He is available to speak with media about this topic – simply click on his icon to arrange an interview.



Connect with:
Zach Jenkins

Zach Jenkins

Associate Professor of Pharmacy Practice & Clinical Specialist, Infectious Diseases

Dr. Zach Jenkins is an infectious disease expert who loves educating others about superbugs, antibiotic therapy, and emergency preparedness.

VaccinesSuperbugsVirusesCOVID-19Infectious Diseases

You might also like...

Check out some other posts from Cedarville University

2 min

Preparing for Tariffs

As President-elect Donald Trump prepares to take office in January, many business owners are preparing for his proposed economic plan to install tariffs on all imported goods. He has also spoken of a plan to add additional tariffs on imports from countries such as China. There is concern that imposing such tariffs would raise the cost of everyday goods in the United States. Looking forward, what are the potential risks and benefits of Trump's tariff plan? Economics expert, Dr. Jared Pincin, recently weighed in on this discussion. Here are three key details from his latest interview: A tariff is a tax on imports. Trump has stated that on his first day in office, he will put a 25% tax on all products coming in from Canada and Mexico. Will this effectively raise revenue without impacting consumers? If these tariffs are actually put into place, Pincin states that they do have the potential to put upward pressure on prices. How would this affect not only consumers, but also business owners? And what can business owners do to prepare for this possibility?  Trump has proposed that tariffs will deter the flow of illegal drugs into the United States, with tariffs putting pressure on countries like Mexico and China. What is the chance that these countries react with their own retaliatory tariffs? If you are covering the the U.S. economy during the Trump administration and need to know more, let us help with your questions and stories. Dr. Jared Pincin is an expert on economics and is available to speak to media regarding the Trump administration and the economy – simply click on his icon or email mweinstein@cedarville.edu to arrange an interview.

2 min

Will TikTok Be Banned?

The social media platform TikTok is on the verge of a U.S. ban—unless it can be stopped by President-elect Donald Trump.  The policy will take effect on January 19, requiring that TikTok find a U.S. parent company or face a ban in the United States. This comes after concerns about user data falling into possession of the Chinese government and fears that they could use TikTok to spread misinformation. Derrick Green, communication expert at Cedarville University, has spoken about the motive behind this ban and why Trump may reverse it. Here are three key points from his recent interview: Trump has pointed out that he would not let TikTok be banned, if elected as president. How could he actually implement this and block this ban from taking effect? The President-elect used TikTok as a part of his campaigning strategy and found success on the app, this coming after he proposed to ban it in 2020. Did his use of TikTok influence his desire to save the app? The proposed ban of TikTok was based on national security and the mental health of young people in the United States. If TikTok was shut down in the United States, what would the effects be? If you are a journalist covering the TikTok ban or the effects of social media, our experts are here to help with all of your questions and stories. Derrick Green is the Chair of the Department of Communication at Cedarville University. Green is available to speak with the media regarding digital media and its effects. Simply click on his icon or email mweinstein@cedarville.edu to arrange an interview.

2 min

The Anxiety of Election Season

After the results of the U.S. presidential election were announced, many Americans celebrated. But many voters instead found only stress and anxiety. After an election of rhetoric that foretold the end of democracy if the opposing candidate won, there seems to be a unique amount of post-election stress. How did election rhetoric affect this outcome, and can we expect future elections to cause this same stress? Political expert, Dr. Mark Caleb Smith, discussed the anxiety that many Americans felt even before the election and how it can be dealt with moving forward. Here are some key takeaways from his recent interview: This election cycle caused so many Americans to lose sleep that the term "electsomnia" was coined. Has the anxiety of election season always been present, or has the presence of social media paved a way for this problem? Constant access to information about the election is a probable reason for many voters' anxiety. How can Americans keep themselves informed without causing unnecessary damage to their mental health? This is not the first complicated or difficult election that the United States has faced. Now that this election season is over, how can Americans—both those who are satisfied and those who are frustrated by the results—move forward while recognizing that politics does not define them? If you are a journalist covering the election results and voters' responses, our experts are here to help with all of your questions and stories. Dr. Mark Caleb Smith is the Director of the Center for Political Studies at Cedarville University. Mark is available to speak with the media regarding election emotions and the election results. Simply click on his icon or email mweinstein@cedarville.edu to arrange an interview.

View all posts
Powered by